141
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Advances in Human-Centered Care to Address Contemporary Unmet Needs in Chronic Dialysis

& ORCID Icon
Pages 91-104 | Received 23 Dec 2023, Accepted 12 Mar 2024, Published online: 19 Mar 2024

References

  • Bonventre JV, Hurst FP, West M, Wu I, Roy-Chaudhury P, Sheldon M. A technology roadmap for innovative approaches to kidney replacement therapies: a catalyst for change. Clin J Am Soc Nephrol. 2019;14(10):1539–1547. doi:10.2215/CJN.02570319
  • Wyld M, Morton RL, Hayen A, Howard K, Webster AC, Turner N. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012;9(9):e1001307. doi:10.1371/journal.pmed.1001307
  • Johnson JP, McCauley CR, Copley JB. The quality of life of hemodialysis and transplant patients. Kidney Int. 1982;22(3):286–291. doi:10.1038/ki.1982.167
  • Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093–2109. doi:10.1111/j.1600-6143.2011.03686.x
  • Australian Institute of Health and Welfare (AIHW). Chronic kidney disease: Australian facts; 2023. Available from: https://www.aihw.gov.au/reports/chronic-kidney-disease/chronic-kidney-disease. Accessed 19 March, 2024.
  • Linde PG, Archdeacon P, Breyer MD, et al. Overcoming barriers in kidney health—forging a platform for innovation. J Am Soc Nephrol. 2016;27(7):1902–1910. doi:10.1681/ASN.2015090976
  • Australian Commission on Safety and Quality in Health Care (ACSQHC). Partnering with Consumers Case Study: Royal Prince Alfred Hospital and Sydney Local Health District; 2021. Available from: https://www.safetyandquality.gov.au/sites/default/files/2021-10/partnering_with_consumers_case_study_royal_prince_alfred_hospital_and_sydney_local_health_district.pdf. Accessed 19 March, 2024.
  • Damasiewicz MJ, Polkinghorne KR. Global dialysis perspective: Australia. Kidney360. 2020;1(1):48–51. doi:10.34067/KID.0000112019
  • Corcoran RM. Maintenance dialysis: the Western Sydney experience. Commun Health Stud. 1980;4(3):188–193. doi:10.1111/j.1753-6405.1980.tb00296.x
  • Cooper BA, Branley P, Bulfone L, et al. The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int. 2004;24(2):176–181. doi:10.1177/089686080402400209
  • Australian and New Zealand Dialysis and Transplant Registry (ANZDATA). 46th Annual Report: summary of data collected to December 31st, 2022; 2023. Available from: https://www.anzdata.org.au/report/anzdata-46th-annual-report-2023-data-to-2022/. Accessed 10 September, 2023.
  • Australian Bureau of Statistics (ABS). Census 2021; 2023. Available from: https://www.abs.gov.au/census. Accessed 19 March, 2024.
  • Kidney Health Australia (KHA). State of the Nation - 2016 Kidney Health Week; 2016. Available from: https://kidney.org.au/uploads/resources/state-of-the-nation-2015.pdf. Accessed 17 September, 2023.
  • Kennard A, Glasgow N, Rainsford S, Talaulikar G. Frailty in chronic kidney disease: challenges in nephrology practice. A review of current literature. Internal Med J. 2023;53(4):465–472. doi:10.1111/imj.15759
  • Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27(1):1–15. doi:10.1016/j.cger.2010.08.009
  • Fraser SDS, Roderick PJ, May CR, et al. Correction to: the burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol. 2020;21(1):543. doi:10.1186/s12882-020-02205-w
  • Clare M, Stewart WM, Bruce G, David H. Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care. Br J Gen Pract. 2021;71(704):e243. doi:10.3399/bjgp20X714125
  • Chowdhury R, Peel NM, Krosch M, Hubbard RE. Frailty and chronic kidney disease: a systematic review. Arch Gerontol Geriatrics. 2017;68:135–142. doi:10.1016/j.archger.2016.10.007
  • Hubbard RE, Peel NM, Smith M, et al. Feasibility and construct validity of a Frailty index for patients with chronic kidney disease. Australas J Ageing. 2015;34(3):E9–E12. doi:10.1111/ajag.12231
  • George CR. History of home haemodialysis in Australia. Nephrology. 2005;10(3):215–221. doi:10.1111/j.1440-1797.2005.00390.x
  • Sharif MU, Elsayed ME, Stack AG. The global nephrology workforce: emerging threats and potential solutions! Clin Kidney J. 2016;9(1):11–22. doi:10.1093/ckj/sfv111
  • Agar JWM, Hawley CM, George CRP, Mathew TH, McDonald SP, Kerr PG. Home haemodialysis in Australia - is the wheel turning full circle? Med j Aust. 2010;192(7):403–406. doi:10.5694/j.1326-5377.2010.tb03565.x
  • Mendu ML, Divino-Filho JC, Vanholder R, et al. Expanding utilization of home dialysis: an action agenda from the First International Home Dialysis Roundtable. Kidney Med. 2021;3(4):635–643. doi:10.1016/j.xkme.2021.04.004
  • Wilkie M. Home dialysis—an international perspective. NDT Plus. 2011;4(suppl_3):iii4–iii6. doi:10.1093/ndtplus/sfr129
  • United States Renal Data System. 2023 USRDS Annual Data Report: epidemiology of kidney disease in the United States; 2023. Available from: https://adr.usrds.org/2023. Accessed March 14, 2024.
  • Apel C, Hornig C, Maddux FW, Ketchersid T, Yeung J, Guinsburg A. Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability. Clin Kidney J. 2021;14(Suppl 4):i98–i113. doi:10.1093/ckj/sfab193
  • NSW Health. Metropolitan Local Health Districts; 2023, Available from: https://www.health.nsw.gov.au/lhd/Pages/default.aspx. Accessed 19 March, 2024.
  • Riaz P, Caskey F, McIsaac M, et al. Workforce capacity for the care of patients with kidney failure across world countries and regions. BMJ Glob Health. 2021;6(1):e004014. doi:10.1136/bmjgh-2020-004014
  • Polkinghorne KR, Kerr PG, Boudville N. Response to COVID-19 infection in hemodialysis patients: an Australian Perspective. Kidney360. 2020;1(8):829–833. doi:10.34067/KID.0002492020
  • Liu N, Kim J, Jung Y, et al. Remote monitoring systems for chronic patients on home hemodialysis: field test of a copresence-enhanced design. JMIR Hum Fact. 2017;4(3):e21. doi:10.2196/humanfactors.7078
  • Baumgart A, Manera KE, Johnson DW, et al. Meaning of empowerment in peritoneal dialysis: focus groups with patients and caregivers. Nephrol Dial Transplant. 2020;35(11):1949–1958. doi:10.1093/ndt/gfaa127
  • Dominello A, Howell M, Craig JC, et al. Equity in national policies for Australians with kidney disease. Aust N Z J Public Health. 2021;45(4):370–375. doi:10.1111/1753-6405.13096
  • Kidney Health Australia. Chronic Kidney Disease (CKD) Management; 2020. Available from: https://kidney.org.au/uploads/resources/CKD-Management-in-Primary-Care_handbook_2020.1.pdf. Accessed 20 November, 2023.
  • Johnson D. When to refer for specialist renal care. Caring for Australia and and New Zealanders with Kidney Impairment; 2012.
  • Rizzolo K, Gonzalez Jauregui R, Barrientos I, et al. Barriers and facilitators to home dialysis among latinx patients with kidney disease. JAMA Network Open. 2023;6(8):e2328944–e2328944. doi:10.1001/jamanetworkopen.2023.28944
  • Schulz PJ, Nakamoto K. The perils of misinformation: when health literacy goes awry. Nat Rev Nephrol. 2022;18(3):135–136. doi:10.1038/s41581-021-00534-z
  • Smith M, e Silva VS, Schick-Makaroff K, et al. Furthering cultural safety in kidney care within indigenous communities: a systematic and narrative review. Kidney Med. 2021;3(6):896–904. doi:10.1016/j.xkme.2021.04.023
  • Rizzolo K, Feldman KE, Dubey M, Powe NR, Cervantes L. The absence of state-wide policy on providing standard dialysis care for undocumented immigrants: challenges and opportunities. Clin J Am Soc Nephrol. 2023;19(1):98–100. doi:10.2215/CJN.0000000000000308
  • Morton RL, Tong A, Webster AC, Snelling P, Howard K. Characteristics of dialysis important to patients and family caregivers: a mixed methods approach. Nephrol Dial Transplant. 2011;26(12):4038–4046. doi:10.1093/ndt/gfr177
  • Manns B, Hemmelgarn B, Lillie E, et al. Setting research priorities for patients on or nearing dialysis. Clin J Am Soc Nephrol. 2014;9(10):1813–1821. doi:10.2215/CJN.01610214
  • Flythe JE, Hilliard T, Castillo G, et al. Symptom prioritization among adults receiving In-center hemodialysis: a mixed methods study. Clin J Am Soc Nephrol. 2018;13(5):735–745. doi:10.2215/CJN.10850917
  • Mehrotra R, Davison SN, Farrington K, et al. Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023;104(3):441–454. doi:10.1016/j.kint.2023.05.019
  • Weisbord SD. Patient-centered dialysis care: depression, pain, and quality of life. Semin Dial. 2016;29(2):158–164. doi:10.1111/sdi.12464
  • Liu FX, Gao X, Inglese G, Chuengsaman P, Pecoits-Filho R, Yu A. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Peritoneal Dialysis Int. 2015;35(4):406–420. doi:10.3747/pdi.2013.00204
  • Jeffrey B, Smolonogov T, Kairaitis L. Influence of timing and patient characteristics on outcomes of a comprehensive pre-dialysis programme in Western Sydney. Presented at: ANZSN; 2017.
  • Mudge DW, Boudville N, Brown F, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to sustain the action. Nephrology. 2016;21(7):535–546. doi:10.1111/nep.12731
  • Boudville N, Cho Y, Equinox KL, et al. Teaching peritoneal dialysis in Australia: an opportunity for improvement. Nephrology. 2018;23(3):259–263. doi:10.1111/nep.12992
  • Htay H, Cho Y, Pascoe EM, et al. Center effects and peritoneal dialysis peritonitis outcomes: analysis of a National Registry. Am J Kidney Dis. 2018;71(6):814–821. doi:10.1053/j.ajkd.2017.10.017
  • Jose MD, Johnson DW, Mudge DW, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology. 2011;16(1):19–29. doi:10.1111/j.1440-1797.2010.01390.x
  • Taskapan H, Tam P, LeBlanc D, et al. Peritoneal dialysis in the nursing home. Int Urol Nephrol. 2010;42(2):545–551. doi:10.1007/s11255-010-9714-y
  • Bethesda M. US renal data system, USRDS annual data report. Atlas Chronic Kidney Dis End-Stage Ren Dis United States Natl Institutes Heal Natl Inst Diabetes Dig Kidney Dis; 2018.
  • Mehrotra R, Khawar O, Duong U, et al. Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and Outcomes. Am J Kidney Dis. 2009;54(2):289–298. doi:10.1053/j.ajkd.2009.01.262
  • Gorham G, Howard K, Zhao Y, et al. Cost of dialysis therapies in rural and remote Australia – a micro-costing analysis. BMC Nephrol. 2019;20(1):231. doi:10.1186/s12882-019-1421-z
  • Mathew A, McLeggon J-A, Mehta N, et al. Mortality and hospitalizations in intensive dialysis: a systematic review and meta-analysis. Can J Kidney Health Dis. 2018;5:2054358117749531. doi:10.1177/2054358117749531
  • Morita PP, Huynh K, Zakir A, et al. Supporting the establishment of new home dialysis programs through the explore home dialysis program. Kidney Int Rep. 2019;4(2):293–300. doi:10.1016/j.ekir.2018.10.019
  • Aydede SK, Komenda P, Djurdjev O, Levin A. Chronic kidney disease and support provided by home care services: a systematic review. BMC Nephrol. 2014;15(1):118. doi:10.1186/1471-2369-15-118
  • Rosner MH, Lew SQ, Conway P, et al. Perspectives from the Kidney Health Initiative on Advancing Technologies to facilitate remote monitoring of patient self-care in RRT. Clin J Am Soc Nephrol. 2017;12(11):1900–1909. doi:10.2215/CJN.12781216
  • Davenport A. Portable and wearable dialysis devices for the treatment of patients with end-stage kidney failure: wishful thinking or just over the horizon? Pediatr Nephrol. 2015;30(12):2053–2060. doi:10.1007/s00467-014-2968-3
  • Anna Jónsdóttir A, Firestone S, Kessler L, Kim J-E. Human factors considerations in designing a portable dialysis device: understanding patients’ and care partners’ needs for increased mobility. Proceed Human Fact Ergon Soc Ann Meet. 2021;65(1):520–524. doi:10.1177/1071181321651151
  • Jónsdóttir AA, Kessler LG, Rim S-Y, Kim J-E. What patients and care partners want in a wearable dialysis device: a mixed-methods study. IISE Trans Healthc Syst Eng. 2022;12(2):101–110. doi:10.1080/24725579.2021.1958273
  • Flythe JE, Forfang D, Gedney N, et al. Development of a Patient Preference Survey for wearable kidney replacement therapy devices. Kidney360. 2022;3(7):1197–1209. doi:10.34067/KID.0001862022
  • Gedney N, Sipma W, Sondergaard H. Innovations in dialysis: the user’s perspective. Nat Rev Nephrol. 2020;16(10):544–545. doi:10.1038/s41581-020-0292-7
  • Dorough A, Forfang D, Mold JW, Kshirsagar AV, DeWalt DA, Flythe JE. A person-centered interdisciplinary plan-of-care program for dialysis: implementation and preliminary testing. Kidney Med. 2021;3(2):193–205.e1. doi:10.1016/j.xkme.2020.11.010
  • González AM, Gutman T, Lopez-Vargas P, et al. Patient and caregiver priorities for outcomes in CKD: a Multinational Nominal Group Technique Study. Am J Kidney Dis. 2020;76(5):679–689. doi:10.1053/j.ajkd.2020.03.022
  • Melles M, Albayrak A, Goossens R. Innovating health care: key characteristics of human-centered design. Int J Qual Health Care. 2021;33(Supplement_1):37–44. doi:10.1093/intqhc/mzaa127
  • Australian Commission on Safety and Quality in Health Care (ACSQHC). Patient-centred care: improving quality and safety by focusing care on patients and consumers; 2011. Available from: https://www.safetyandquality.gov.au/sites/default/files/migrated/PCC_Paper_August.pdf. Accessed 19 March, 2024.
  • Beach MC, Sugarman J, Johnson RL, Arbelaez JJ, Duggan PS, Cooper LA. Do patients treated with dignity report higher satisfaction, adherence, and receipt of preventive care? Ann Fam Med. 2005;3(4):1544–1717. Electronic.
  • Arbuthnott A, Sharpe D. The effect of physician–patient collaboration on patient adherence in non-psychiatric medicine. Patient Educ Couns. 2009;77(1):60–67. doi:10.1016/j.pec.2009.03.022
  • Glickman SW, Boulding W, Manary M, et al. Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction. Circulation. 2010;3(2):188–195. doi:10.1161/CIRCOUTCOMES.109.900597
  • Stone S. A retrospective evaluation of the impact of the planetree patient-centered model of care on inpatient quality outcomes. HERD. 2008;1(4):55–69. doi:10.1177/193758670800100406
  • Sweeney L, Halpert A, Fau - Waranoff J, Waranoff J. Patient-centered management of complex patients can reduce costs without shortening life. Am J Manag Care. 2007;13(2):1936–2692.
  • Charmel PA, Frampton SB. Building the business case for patient-centered care. Healthc Financ Manag. 2008;62(3):0732–0735.
  • Crail S, Walker R, Brown M; Renal Supportive Care working g. Renal supportive and palliative care: position statement. Nephrology. 2013;18(6):393–400. doi:10.1111/nep.12064
  • So S, Brennan FP, Li KC, Brown MA. End-stage kidney disease: the last 12 months. Aust J Gen Pract. 2021;50(4):193–198. doi:10.31128/AJGP-11-20-5736
  • Siriwardana AN, Hoffman AT, Brennan FP, Li K, Brown MA. Impact of renal supportive care on symptom burden in dialysis patients: a Prospective Observational Cohort Study. J Pain Symptom Manage. 2020;60(4):725–736. doi:10.1016/j.jpainsymman.2020.04.030
  • Sobels E, Best M, Chadban S, Pais R. End stage kidney disease patient experiences of renal supportive care in an Australian Teaching Hospital - a qualitative study. J Pain Symptom Manage. 2022;63(5):737–746. doi:10.1016/j.jpainsymman.2021.12.024
  • Chia XX, Johnston R, Aggarwal R, et al. Renal supportive care programs: an observational study assessing impact on hospitalization and survival outcomes. Nephrology. 2021;26(6):522–529. doi:10.1111/nep.13869
  • Roumelioti M-E, Steel JL, Yabes J, et al. Rationale and design of technology assisted stepped collaborative care intervention to improve patient-centered outcomes in hemodialysis patients (TĀCcare trial). Contemp Clin Trials. 2018;73:81–91. doi:10.1016/j.cct.2018.09.002
  • Johnson JA, Al Sayah F, Buzinski R, et al. A cluster randomized controlled trial for the Evaluation of routinely Measured PATient reported outcomes in HemodialYsis care (EMPATHY): a study protocol. BMC Health Serv Res. 2020;20(1):731. doi:10.1186/s12913-020-05557-z
  • Unruh M, Cukor D, Rue T, et al. Sleep-HD trial: short and long-term effectiveness of existing insomnia therapies for patients undergoing hemodialysis. BMC Nephrol. 2020;21(1):443. doi:10.1186/s12882-020-02107-x
  • Greenham L, Bennett PN, Dansie K, et al. The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis. Trials. 2022;23(1):419. doi:10.1186/s13063-022-06355-0
  • Australia D. Home dialysis; 2023. https://www.dialysisaustralia.com.au/home-dialysis.html. Accessed December 10, 2023.
  • Nel H, Debbie F, Narelle H, Sean R, Aron C. A retrospective clinical and economic analysis of an assisted automated peritoneal dialysis programme in Western Australia. Perit Dial Int. 2023;8968608231190772. doi:10.1177/08968608231190772
  • Gautier N, Ficheux M, Henri P, Lanot A, Béchade C, Allard B. Innovations en hémodialyse à domicile: innovations in home hemodialysis. Néphrologie Thérapeutique. 2022;18(5, Supplement 1):5S2–5S11. doi:10.1016/S1769-7255(23)00004-4
  • Gogoi S. Nurse-assisted home hemodialysis with NxStage system one portable machine: an Experience in the Gulf Cooperation Council (GCC); 2023.
  • Hamad A, Mohamed M, Elshirbeny M, et al. Assisted home hemodialysis: a game-changer for patients and providers; 2023.
  • Australian Commission on Safety and Quality in Health Care (ACSQHC). Review of key attributes of high-performing person-centred healthcare organisations; 2018. Available from: https://www.safetyandquality.gov.au/sites/default/files/migrated/FINAL-REPORT-Attributes-of-person-centred-healthcare-organisations-2018.pdf. Accessed 19 March, 2024.
  • Kalantar-Zadeh K, Pk-t L, Tantisattamo E, et al. Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere. J Nephrol. 2021;34(2):381–388. doi:10.1007/s40620-021-01000-6
  • Morfín JA, Yang A, Wang E, Schiller B. Transitional dialysis care units: a new approach to increase home dialysis modality uptake and patient outcomes. Semin Dial. 2018;31(1):82–87. doi:10.1111/sdi.12651
  • Blankenship DM, Usvyat L, Kraus MA, et al. Assessing the impact of transitional care units on dialysis patient outcomes: a multicenter, propensity score-matched analysis. Hemodial Int. 2023;27(2):1542–4758. Electronic. doi:10.1111/hdi.13068
  • Soi V, Faber MD, Paul R. Incremental hemodialysis: what we know so far. Int J Nephrol Renovasc Dis. 2022;15:161–172. doi:10.2147/IJNRD.S286947
  • Hegerty K, Jaure A, Scholes-Robertson N, et al. Australian Workshops on patients’ perspectives on hemodialysis and incremental start. Kidney Int Rep. 2023;8(3):478–488. doi:10.1016/j.ekir.2022.11.012
  • Murashima M, Hamano T, Abe M, Masakane I. Combination of once-weekly haemodialysis with peritoneal dialysis is associated with lower mortality compared with peritoneal dialysis alone: a longitudinal study. Clin Kidney J. 2021;14(6):1610–1617. doi:10.1093/ckj/sfaa173
  • Giacomo M, Gaetano A, Francesco F, Riccardo M. Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic. BMJ Case Rep. 2020;13(10):e236411. doi:10.1136/bcr-2020-236411
  • Chung M-C, T-m Y, M-j W, et al. Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan. BMC Nephrol. 2020;21(1):348. doi:10.1186/s12882-020-01989-1
  • Watanabe Y, Okada H. Effect of combined peritoneal dialysis and hemodialysis on health-related quality of life. Recent Adv Dialysis Therap Japan. 2018. doi:10.1159/000485713
  • Maruyama Y, Yokoyama K, Nakayama M, et al. Combined therapy with peritoneal dialysis and hemodialysis: a multicenter retrospective observational cohort study in Japan. Blood Purificat. 2014;38(2):149–153. doi:10.1159/000368389
  • American Society of Nephrology. End-Stage Kidney Disease: NepSAP. Vol. 22. American Society of Nephrology; 2023. Available from: https://nephsap.org/view/journals/nephsap/22/2/nephsap.22.issue-2.xml. Accessed March 19, 2024.
  • Geremia I, Stamatialis D. Innovations in dialysis membranes for improved kidney replacement therapy. Nat Rev Nephrol. 2020;16(10):550–551. doi:10.1038/s41581-020-0293-6
  • Geremia I, Bansal R, Stamatialis D. In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma. Acta Biomater. 2019;90:100–111. doi:10.1016/j.actbio.2019.04.009
  • Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388(10041):294–306. doi:10.1016/S0140-6736(16)30448-2
  • Ronco C, Cruz D. Hemodiafiltration history, technology, and clinical results. Adv Chronic Kidney Dis. 2007;14(3):231–243. doi:10.1053/j.ackd.2007.04.002
  • Mercadal L, Franck J-E, Metzger M, et al. Hemodiafiltration versus hemodialysis and survival in patients with ESRD: the French Renal Epidemiology and Information Network (REIN) Registry. Am J Kidney Dis. 2016;68(2):247–255. doi:10.1053/j.ajkd.2015.11.016
  • Ok E, Asci G, Toz H, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant. 2013;28(1):192–202. doi:10.1093/ndt/gfs407
  • Morena M, Jaussent A, Chalabi L, et al. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int. 2017;91(6):1495–1509. doi:10.1016/j.kint.2017.01.013
  • Lang T, Zawada AM, Theis L, et al. Hemodiafiltration: technical and medical insights. Bioengineering. 2023;10(2):145. doi:10.3390/bioengineering10020145
  • Peters SAE, Bots M, Canaud B, et al. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant. 2016;31(6):978–984. doi:10.1093/ndt/gfv349
  • Blankestijn PJ, Vernooij RWM, Hockham C, et al. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med. 2023;389(8):700–709. doi:10.1056/NEJMoa2304820
  • Golper TA. Improving dialysis techniques for patients? N Engl J Med. 2023;389(8):762–763. doi:10.1056/NEJMe2307709
  • Cahill Z, Conway PT, Lim MD. Reducing the risks of home dialysis innovation and uptake: the case for human-centered product design. Clin J Am Soc Nephrol. 2022;17(11):1688–1690. doi:10.2215/CJN.05100422
  • Gura V, Rivara MB, Bieber S, et al. A wearable artificial kidney for patients with end-stage renal disease. JCI Insight. 2016;1(8). doi:10.1172/jci.insight.86397
  • Htay H, Gow SK, Jayaballa M, et al. Preliminary safety study of the Automated Wearable Artificial Kidney (AWAK) in Peritoneal Dialysis patients. Peritoneal Dialysis Int. 2021;42(4):394–402. doi:10.1177/08968608211019232
  • Groth T, Stegmayr BG, Ash SR, et al. Wearable and implantable artificial kidney devices for end-stage kidney disease treatment: current status and review. Artif. Organs. 2023;47(4):649–666. doi:10.1111/aor.14396
  • Ramada DL, de Vries J, Vollenbroek J, et al. Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges. Nat Rev Nephrol. 2023;19(8):481–490. doi:10.1038/s41581-023-00726-9
  • Fissell WH, Roy S. Innovation in the treatment of uremia: proceedings from the Cleveland Clinic workshop: the implantable artificial kidney. Semin Dial. 2009;22(6):665–670. doi:10.1111/j.1525-139X.2009.00662.x
  • Kim EJ, Chen C, Gologorsky R, et al. Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes. Nat Commun. 2023;14(1):4890. doi:10.1038/s41467-023-39888-2
  • Barbieri C, Molina M, Ponce P, et al. An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients. Kidney Int. 2016;90(2):422–429. doi:10.1016/j.kint.2016.03.036
  • Kim HW, Heo S-J, Kim M, et al. Deep learning model for predicting intradialytic hypotension without privacy infringement: a retrospective two-center study. Original Research. Front Med. 2022;9. doi:10.3389/fmed.2022.878858
  • Ayers JW, Poliak A, Dredze M, et al. Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum. JAMA Intern Med. 2023;183(6):589–596. doi:10.1001/jamainternmed.2023.1838
  • Fayos De Arizón L, Viera ER, Pilco M, et al. Artificial intelligence: a new field of knowledge for nephrologists? Clin Kidney J. 2023:sfad182. doi:10.1093/ckj/sfad182
  • Erickson KF, Warrier A, Wang V. Market Consolidation and Innovation in US dialysis. Adv Chronic Kidney Dis. 2022;29(1):65–75. doi:10.1053/j.ackd.2022.01.002